bf/NASDAQ:GLUE_icon.jpeg

COM:MONTEROSATX

Monte Rosa Therapeutics

  • Stock

Last Close

8.84

05/11 21:00

Market Cap

238.49M

Beta: -

Volume Today

683.62K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
cash per share
0.54
-
1.92
256.60%
13.84
621.63%
5.57
59.80%
4.52
18.75%
company equity multiplier
-0.91
-
-1.01
10.96%
1.05
204.03%
1.26
19.67%
1.69
34.33%
days of inventory outstanding
days of payables outstanding
654.21
-
days of sales outstanding
dividend yield
ebit per revenue
ebt per ebit
0.97
-
1.28
32.30%
1.01
20.78%
0.97
4.86%
0.94
2.42%
effective tax rate
-0.04
-
-0.01
85.28%
0.03
617.47%
0.04
31.29%
-0.00
107.00%
enterprise value multiple
-30.18
-
-15.35
49.14%
-2.26
85.27%
-3.12
38.17%
-1.52
51.36%
fixed asset turnover
free cash flow per share
-0.68
-
-1.22
79.36%
-2.76
127.21%
-2.23
19.27%
-1.22
45.20%
gross profit margin
interest coverage
-7.99K
-
-29.86
-
inventory turnover
long term debt to capitalization
0.14
-
0.19
38.71%
net income per ebt
1.04
-
1.01
2.95%
0.97
3.24%
0.96
0.88%
1.00
3.97%
net profit margin
operating cash flow per share
-0.55
-
-1.06
91.46%
-2.37
123.90%
-1.96
17.55%
-0.85
56.47%
operating profit margin
payables turnover
0.56
-
pretax profit margin
price fair value
-19.43
-
-9.45
51.37%
1.47
115.55%
1.32
9.86%
1.62
22.34%
receivables turnover
return on assets
-0.72
-
-0.73
1.08%
-0.20
73.11%
-0.31
55.59%
-0.45
45.83%
return on capital employed
-1.18
-
-1.39
18.56%
-0.21
85.04%
-0.35
70.20%
-0.56
57.10%
return on equity
0.66
-
0.74
12.16%
-0.21
127.97%
-0.39
86.19%
-0.76
95.90%
total debt to capitalization
-0.07
-
0.15
-
0.20
38.44%

All numbers in (except ratios and percentages)